Morning Hubsters, John R Fischer here with the US Wire from the New York newsroom. The consistent need to replenish gloves, syringes and other medical consumables has created strong demand that has caught the eye of BC Partners, Brookfield, CDPQ and other PE firms that I highlighted in my 6-deal listicle. Pharma commercialization is another sector where demand is picking up. Linden Capital Partners and GIC are among the latest firms to make a move in the segment. We’ll dive into the details of that investment as part of Friday Focus. Deal volume in the vitamins and supplements sector has increased by quite a margin from last year’s figures, according to Capstone Partners’ latest M&A report. We’ve got more details on that below. Let’s dive in. Gloves on From gloves and syringes to suction and irrigation systems, the market for medical consumables is poised for expansion, according to the latest medical consumables M&A report by business management consulting firm Alvarez & Marsal. Starting with the most recent, PE Hub rounded up six deals from July and the first half of the year in the medical consumables sector. Premium subscribers of the Wire can read the full list of deals. Friday Focus Linden Capital Partners and GIC earlier this week announced theirinvestment in Klick Group, a life sciences commercialization agency based in Toronto. Life science commercialization companies have recently become sought-after targets for notable PE firms, including Permira, Odyssey Investment Partners and THL Partners. I highlighted earlier this year in my 5-deal listicle on pharma marketing investments. PE Hub Senior Reporter Michael Schoeck included the Klick deal, along with two others, in the Wire earlier this week in his companies for sale update. Upgrade to the premium version of the Wire for more details on the Klick deal. Take your vitamins Investments in vitamins and supplements rose 36.8 percent in volume, from 19 announced or completed transactions in 2024 to 26 in 2025, according to Capstone Partners’ Vitamins & Supplements M&A Report. Some recent PE-backed deals in the sector include:
Palm Beach Capital backs Growve Enterprise Investors to take majority stake in Formeds Kingswood Capital and Performance Investment Partners to acquire The Vitamin Shoppe EQT to sell Karo to KKR PE Hub’s Sophie Rose highlighted a slew of vitamin and supplement deals from early 2025 and 2024 in an 11-deal listicle. Sophie also delved deeper to explore the trends driving PE investments in the sector in a recent feature. Premium subscribers of the Wire can read more of the highlights I included from the report. Well, that’s it for me. As always, if you have any questions, comments or want to chat, feel free to drop me a note at john.fischer@pei.group. Nina Lindholm will be back with you on Monday in the Europe chair, and MK Flynn will bring you the US Wire. Cheers, John Read the full Wire commentary on PE Hub ... | 